000 04076nam a2200409 i 4500
999 _c396513
_d396513
001 396513
003 ES-MaUEC
005 20240202104129.0
006 a|||| o|||| 00| 0
007 cr nn 008mamaa
008 211015s2022 xxua o |||| 0|eng d
020 _a9781071617120
024 7 _a10.1007/978-1-0716-1712-0
_2doi
040 _aES-MaUEC
_bspa
_cES-MaUEC
_dES-MaUEC
050 4 _aRC394 .D35
_b2022 EB
245 0 0 _aNeurodegenerative Diseases Biomarkers :
_bTowards Translating Research to Clinical Practice
_cedited by Philip V. Peplow, Bridget Martinez, Thomas A. Gennarelli
250 _a1st edition 2022
264 1 _aNew York, NY
_bSpringer International Publising
_c2022
300 _a1 recurso en línea (XVIII, 565 páginas)
_b48 ilustraciones, 42 ilustraciones a color
336 _atexto
_btxt
_2rdacontent
337 _aelectrónico
_bc
_2rdamedia
338 _arecurso electrónico
_bcr
_2rdacarrier
347 _aarchivo de texto
_bPDF
490 0 _aNeuromethods
_x1940-6045
_v173
505 0 _aPrevalence, Needs, Strategies, and Risk Factors for Neurodegenerative Diseases. Activation of Microglia and Macrophages in Neurodegenerative Diseases -- Activation of Astrocytes in Neurodegenerative Diseases -- Tau Pathology in Neurodegenerative Diseases -- Role of SIRT3 and Mitochondrial Dysfunction in Neurodegeneration -- Oxidative Stress and Cellular Dysfunction in Neurodegeneratiove Disease -- Biomarkers in Parkinson's Disease -- Metabolomic Biomarkers in Parkinson's Disease -- Neuroinflammation in Huntington's Disease -- Biomarkers in Huntington Disease -- Biofluid Biomarkers of Amyotrophic Lateral Sclerosis -- MicroRNAs in Blood Serum, Blood Plasma, and Cerebrospinal Fluid as Diagnostic Biomarkers of Alzheimer's Disease -- Tau Biomarkers for Long-Term Effects of Neurotrauma: Technology Versus the Null Hypothesis -- Impedimetric Immunosensing for Neuroinflammatory Biomarker Profiling -- Aptamers Detection of Neurodegenerative Disease Biomarkers -- Possible Biomarkers for Frontotemporal Dementia and to Differentiate from Alzheimer's Disease and Amyotrophic Lateral Sclerosis -- TSPO PET Imaging as a Biomarker of Neuroinflammation in Neurodegenerative Disorders -- Validation of Diffusion Kurtosis Imaging as an Early Stage Biomarker of Parkinson's Disease in Animal Models -- Imaging Biomarkers in Huntington's Disease -- Imaging Biomarkers in Amyotrophic Lateral Sclerosis -- Trends in Biomarkers of Neurodegenerative Diseases.
520 _aThis volume presents recent data on the latest achievements in new and emerging technologies for biomarkers and for innovations in their assessment. The chapters cover topics such as activation of microglia and macrophages in neurodegenerative diseases; oxidative stress and cellular dysfunction in neurodegenerative diseases; TSPO PET imaging as a biomarker of neuroinflammation in neurodegenerative disorders; and imaging biomarkers in Huntington's disease and amyotrophic lateral sclerosis. In the Neuromethods series style, chapters include the kind of detail and key advice from the specialists needed to get successful results in your laboratory. Cutting-edge and comprehensive, Neurodegenerative Diseases Biomarkers: Towards Translating Research to Clinical Practice is a valuable resource for both experimental and clinical experts in the field of neurodegenerative diseases who are looking to expand their knowledge of novel biomarkers in different types of neurodegenerative diseases.
988 _aSpringer_Protocols_2022
650 7 _2embne
_9313064
_aSistema nervioso
_xDegeneración
650 7 _2embne
_9162047
_aMarcadores biológicos
776 0 8 _iPrinted edition:
_z9781071617113
776 0 8 _iPrinted edition:
_z9781071617137
776 0 8 _iPrinted edition:
_z9781071617144
856 4 0 _uhttps://go.openathens.net/redirector/universidadeuropea.es?url=https://doi.org/10.1007/978-1-0716-1712-0
_zAcceso a este recurso digital (usuarios Universidad Europea de Madrid)
942 _2lcc
_cLE
998 _b07/2023
_dz
_eb
_zSI